Abstract
To clarify the possible pathogenetic role of oxidation products originated from the glycation of proteins, human globins from nephropathic patients have been studied by matrix-assisted laser desorption/ionization mass spectrometry (MALDI), revealing not only unglycated and monoglycated globins, but also a series of different species. For the last ones, structural assignments were tentatively done on the basis of observed masses and expectations for the Maillard reaction pattern. Consequently, they must be considered only propositive, and the discussion which will follow must be considered in this view. In our opinion this approach does not seem to compromise the intended diagnostic use of the data because distinctions are valid even if the assignments are uncertain. We studied nine healthy subjects and 19 nephropathic patients and processed the data obtained from the MALDI spectra using a multivariate analysis. Our results showed that multivariate analytical techniques enable differential aspects of the profile of molecular species to be identified in the blood of end stage nephropathic patients. A correct grouping can be achieved by principal component analysis (PCA) and the results suggest that several products involved in carbonyl stress exist in nephropathic patients. These compounds may have a relevant role as specific markers of the pathological state.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Dalle-Donne, I.; Giustarini, D.; Colombo, R.; Rossi, R.; Milzani, A. Protein Carbonylation in Human Diseases. Trends Mol. Med. 2003, 9, 169–176.
Oberg, B. P.; McMenamin, E.; Lucas, F. L.; McMonagle, E.; Morrow, J.; Ikizler, T. A.; Himmelfarb, J. Increased Prevalence of Oxidant Stress and Inflammation in Patients with Moderate to Severe Chronic Kidney Disease. Kidney Int. 2004, 65, 1009–1016.
Sugiyama, S.; Miyata, T.; Ueda, Y.; Tanaka, H.; Maeda, K.; Kawashima, S.; van Ypersele-de Strihou, C.; Kurokawa, K. Plasma Levels of Pentosidine in Diabetic Patients: An Advanced Glycation End Product. J. Am. Soc. Nephrol. 1998, 9, 1681–1688.
Miyata, T.; Saito, A.; Kurokawa, K.; van Ypersele de Strihou, C. Advanced Glycation and Lipoxidation End Products: Reactive Carbonyl Compounds-Related Uraemic Toxicity. Nephrol. Dial. Transplant. 2001, 16, 8–11.
Dursun, E.; Dursun, B.; Suleymanlar, G.; Ozben, T. Carbonyl Stress in Chronic Renal Failure: The Effect of Hemodialysis. Ann. Clin. Biochem. 2005, 42, 64–66.
Bohlender, J. M.; Franke, S.; Stein, G.; Wolf, G. Advanced Glycation End Products and the Kidney. Am. J. Physiol. Renal. Physiol. 2005, 289, 645–659.
Kalousova, M.; Zima, T.; Tesar, V.; Dusilova-Sulkova, S.; Skrha, J. Advanced Glycoxidation End Products in Chronic Diseases—Clinical Chemistry and Genetic Background. Mutat. Res. 2005, 11, 37–46.
Odani, H.; Shinzato, T.; Matsumoto, Y.; Usami, J.; Maeda, K. Increase in Three α,β-Dicarbonyl Compound Levels in Human Uremic Plasma: Specific in Vivo Determination of Intermediates in Advanced Maillard Reaction. Biochem. Biophys. Res. Commun. 1999, 256, 89–93.
Wada, T.; Miyata, T.; Kurokawa, K. Implication of Carbonyl Stress in Long-Term Uraemic Complications. Nephrol. Dial. Transplant. 1999, 14, 79–81.
Miyata, T.; Sugiyama, S.; Saito, A.; Kurokawa, K. Reactive Carbonyl Compounds Related Uremic Toxicity (“carbonyl stress”). Kidney Int. Suppl. 2001, 78, 25–31.
Sell, D. R.; Monnier, V. M. Structure Elucidation of a Senescence Cross-Link from Human Extracellular Matrix: Implication of Pentoses in the Aging Process. J. Biol. Chem. 1989, 264, 21597–21602.
Baynes, J. W.; Monnier, V. M., Eds.; The Maillard Reaction in Aging, Diabetes and Nutrition; Alan R. Liss: New York, 1989, pp. 1–395.
Dyer, D. G.; Blackledge, J. A.; Thorpe, S. R.; Baynes, J. W. Formation of Pentosidine During Nonenzymatic Browning of Proteins by Glucose: Identification of Glucose and Other Carbohydrates as Possible Precursors of Pentosidine in Vivo. J. Biol. Chem. 1991, 266, 11654–11660.
Stopper, H.; Schupp, N.; Bahner, U.; Sebekova, K.; Klassen, A.; Heidland, A. Genomic Damage in End-Stage Renal Failure: Potential Involvement of Advanced Glycation End Products and Carbonyl Stress. Semin. Nephrol. 2004, 24, 474–478.
Smith, A. J.; Lutgers, H. L. The Clinical Relevance of Advanced Glycation End (AGE) and Recent Developments in Pharmaceutics to Reduce AGE Accumulation. Curr. Med. Chem. 2004, 11, 2767–2784.
Tomizawa, H.; Yamazaki, M.; Kunika, K.; Itakura, M.; Yamashita, K. Association of Elastin Glycation and Calcium Deposit in Diabetic Rat Aorta. Diabetes Res. Clin. Pract. 1993, 19, 1–8.
Taniguchi, N.; Kaneto, H.; Asahi, M.; Takahashi, M.; Wenyi, C.; Higashiyama, S.; Fujii, J.; Suzuki, K.; Kayanoki, Y. Involvement of Glycation and Oxidative Stress in Diabetic Macroangiopathy. Diabetes. 1996, 3, 81–83.
Zoccali, C.; Mallamaci, F.; Tripepi, G. AGEs and Carbonyl Stress: Potential Pathogenetic Factors of Long-Term Uraemic Complications. Nephrol. Dial. Transplant. 2000, 15, 7–11.
Miyata, T.; Ueda, Y.; Yamada, Y.; Izuhara, Y.; Wada, T.; Jadoul, M.; Saito, A.; Kurokawa, K.; van Ypersele de Strihou, C. Accumulation of Carbonyls Accelerates the Formation of Pentosidine, an Advanced Glycation End Product: Carbonyl Stress in Uremia. J. Am. Soc. Nephrol. 1998, 9, 2349–2356.
Inagi, R.; Miyata, T. Oxidative Protein Damage with Carbohydrates and Lipids in Uremia: Carbonyl stress. Blood Purif. 1999, 17, 95–98.
Suzuki, D.; Miyata, T.; Kurokawa, K. Carbonyl Stress. Contrib. Nephrol. 2001, 134, 36–45.
Vlassara, H. Advanced Glycation in Health and Disease: Role of the Modern Environment. Ann. N.Y. Acad. Sci. 2005, 1043, 452–460.
Antolini, F.; Valente, F.; Ricciardi, D.; Baroni, M.; Fagugli, R. M. Principal Component Analysis of Some Oxidative Stress Parameters and Their Relationships in Hemodialytic and Transplanted Patients. Clin. Chim. Acta. 2005, 358, 87–94.
Lapolla, A.; Fedele, D.; Aronica, R.; Garbeglio, M.; D’Alpaos, M.; Plebani, M.; Seraglia, R.; Traldi, P. A Highly Specific Method for the Characterization of Glycation and Glycoxidation Products of Globins. Rapid Commun. Mass Spectrom. 1997, 11, 613–617.
Lapolla, A.; Fedele, D.; Plebani, M.; Aronica, R.; Garbeglio, M.; Seraglia, R.; D’Alpaos, M.; Traldi, P. Evaluation of Glycated Globins by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry. Clin. Chem. 1999, 45, 288–290.
Lapolla, A.; Fedele, D.; Traldi, P. Glyco-oxidation in diabetes and related diseases. Clin. Chim. Acta. 2005, 24, 236–250.
Lapolla, A.; Reitano, R.; Seraglia, R.; Sartore, G.; Ragazzi, E.; Traldi, P. Evaluation of Advanced Glycation end Products and Carbonyl Compounds in Patients with Different Conditions of Oxidative Stress. Mol. Nutr. Food Res. 2005, 49, 685–690.
Lapolla, A.; Tubaro, M.; Fedele, D.; Reitano, R.; Arico, N. C.; Ragazzi, E.; Seraglia, R.; Vogliardi, S.; Traldi, P. A Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Study of the Nonenzymatic Glycation Products of Human Globins in Diabetes. Rapid Commun. Mass Spectrom. 2005, 19, 162–168.
Lapolla, A.; Tubaro, M.; Reitano, R.; Arico, N. C.; Ragazzi, E.; Seraglia, R.; Vogliardi, S.; Traldi, P.; Fedele, D. The Complexity of Nonenzymatic Glycation Product Sets of Human Globins. Diabetologia. 2005, 47, 1712–1715.
Roberts, N. B.; Green, B. N.; Morris, M. Potential of Electrospray Mass Spectrometry for Quantifying Glycohemoglobin. Clin. Chem. 1997, 43, 771–778.
Wong, J. W. H.; Cagney, G.; Cartwright, H. M. SpecAlign—Processing and Alignment of Mass Spectra Datasets. Bioinformatics. 2005, 21, 2088–2090.
Xia, X.; Xie, Z. AMADA: Analysis of Microarray Data. Bioinformatics. 2001, 17, 569–570.
Hartigan, J.; Wong, M. A. K-Means Clustering Algorithm. Applied Statistics. 1979, 28, 100–108.
Greenacre, M. J. Correspondence Analysis in Practice, 1st ed.; Academic Press: London, 1993, pp. 1–256.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published online March 30, 2007
Rights and permissions
About this article
Cite this article
Lapolla, A., Ragazzi, E., Andretta, B. et al. Multivariate analysis of matrix-assisted laser desorption/ionization mass spectrometric data related to glycoxidation products of human globins in nephropathic patients. J Am Soc Mass Spectrom 18, 1018–1023 (2007). https://doi.org/10.1016/j.jasms.2007.02.011
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jasms.2007.02.011